NCT02253420 COPANLISIB (BAY80-6946) Drug-drug Interaction and Cardiovascular Safety Study in Advanced Solid Tumor and Non-Hodgkin's Lymphoma Patients Status COMPLETED Phase PHASE1
NCT02138799 A Study to Evaluate How a Drug That Alters Liver Enzymes (Rifampin) Affects the Metabolism of Enzalutamide in Men Status COMPLETED Phase PHASE1
NCT02097953 Influence of Rifampin Co-Administration on the Pharmacokinetic Profile of Daptomycin Status COMPLETED Phase EARLY_PHASE1
NCT02055703 A 3-Part, Open-Label, Drug-Drug Interaction Study of Concomitant Administration of E2609 With Itraconazole, Rifampin, Digoxin, or Donepezil Status COMPLETED Phase PHASE1
NCT02024555 Phase II Investigation of Antimycobacterial Therapy on Progressive, Pulmonary Sarcoidosis Status COMPLETED Phase PHASE2
NCT01969682 A Study to Assess the Effect of Rifampin on the Metabolism of ABT-199 Status WITHDRAWN Phase PHASE1
NCT01953731 A Study To Investigate The Drug-Drug Interaction Potential Of Rifampin OnThe Investigational Agent Palbociclib (PD-0332991) Status COMPLETED Phase PHASE1
NCT01947777 Phase 1 Study in Healthy Subjects to Evaluate the Effect of Rifampin on the Pharmacokinetics of IPI-145 Status COMPLETED Phase PHASE1
NCT01940510 A Study of the Effect of Multiple Doses of Rifampin on the Single Dose Pharmacokinetics of RO5424802 Status COMPLETED Phase PHASE1
NCT01908582 A Study of Evacetrapib and Rifampin in Healthy Participants Status COMPLETED Phase PHASE1
NCT01844583 Safety, Tolerability and Pharmacokinetic (PK) of Concomitant Esomeprazole and Rifampin, and QT Study on Single and Multiple-doses of Alisertib Status COMPLETED Phase PHASE1
NCT01814709 A Drug Interaction Study of GDC-0032 Co-administered With Rifampin or Itraconazole in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01768663 A Phase 1 Study to Examine the Drug-Drug Interaction of Ciprofloxacin, Itraconazole, and Rifampin on the Combination of Lumacaftor With Ivacaftor in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01765543 A Pharmacokinetics (PK) Study to Investigate the Effect of Rifampin on PK of Vemurafenib (Zelboraf) Status COMPLETED Phase PHASE1
NCT01763021 A Study to Assess the Effect of Rifampin on the Pharmacokinetics of PCI-32765 in Healthy Participants Status COMPLETED Phase PHASE1
NCT01757236 Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection Status UNKNOWN Phase PHASE2
NCT01756924 Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection Status TERMINATED Phase PHASE2
NCT01637636 Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin. Status COMPLETED Phase PHASE1
NCT01601626 Rifampin-Based Tuberculosis Treatment Versus Rifabutin-Based Tuberculosis Treatment in Persons With HIV Status TERMINATED Phase PHASE2